IBDEI0CF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5368,0)
 ;;=F03.91^^40^366^25
 ;;^UTILITY(U,$J,358.3,5368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5368,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,5368,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,5368,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,5369,0)
 ;;=G30.0^^40^366^9
 ;;^UTILITY(U,$J,358.3,5369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5369,1,3,0)
 ;;=3^Alzheimer's w/ Early Onset
 ;;^UTILITY(U,$J,358.3,5369,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,5369,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,5370,0)
 ;;=G30.1^^40^366^10
 ;;^UTILITY(U,$J,358.3,5370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5370,1,3,0)
 ;;=3^Alzheimer's w/ Late Onset
 ;;^UTILITY(U,$J,358.3,5370,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,5370,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,5371,0)
 ;;=G30.8^^40^366^7
 ;;^UTILITY(U,$J,358.3,5371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5371,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,5371,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,5371,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,5372,0)
 ;;=G30.9^^40^366^8
 ;;^UTILITY(U,$J,358.3,5372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5372,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,5372,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,5372,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,5373,0)
 ;;=G45.9^^40^366^71
 ;;^UTILITY(U,$J,358.3,5373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5373,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack (TIA),Unspec
 ;;^UTILITY(U,$J,358.3,5373,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,5373,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,5374,0)
 ;;=G47.00^^40^366^49
 ;;^UTILITY(U,$J,358.3,5374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5374,1,3,0)
 ;;=3^Insomnia,Unspec
 ;;^UTILITY(U,$J,358.3,5374,1,4,0)
 ;;=4^G47.00
 ;;^UTILITY(U,$J,358.3,5374,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,5375,0)
 ;;=G47.30^^40^366^65
 ;;^UTILITY(U,$J,358.3,5375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5375,1,3,0)
 ;;=3^Sleep Apnea,Unspec
 ;;^UTILITY(U,$J,358.3,5375,1,4,0)
 ;;=4^G47.30
 ;;^UTILITY(U,$J,358.3,5375,2)
 ;;=^5003977
 ;;^UTILITY(U,$J,358.3,5376,0)
 ;;=G47.9^^40^366^66
 ;;^UTILITY(U,$J,358.3,5376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5376,1,3,0)
 ;;=3^Sleep Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,5376,1,4,0)
 ;;=4^G47.9
 ;;^UTILITY(U,$J,358.3,5376,2)
 ;;=^5003990
 ;;^UTILITY(U,$J,358.3,5377,0)
 ;;=G93.3^^40^366^61
 ;;^UTILITY(U,$J,358.3,5377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5377,1,3,0)
 ;;=3^Postviral Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,5377,1,4,0)
 ;;=4^G93.3
 ;;^UTILITY(U,$J,358.3,5377,2)
 ;;=^5004181
 ;;^UTILITY(U,$J,358.3,5378,0)
 ;;=I73.01^^40^366^64
 ;;^UTILITY(U,$J,358.3,5378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5378,1,3,0)
 ;;=3^Raynaud's Syndrome w/ Gangrene
 ;;^UTILITY(U,$J,358.3,5378,1,4,0)
 ;;=4^I73.01
 ;;^UTILITY(U,$J,358.3,5378,2)
 ;;=^5007797
 ;;^UTILITY(U,$J,358.3,5379,0)
 ;;=I96.^^40^366^41
 ;;^UTILITY(U,$J,358.3,5379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5379,1,3,0)
 ;;=3^Gangrene NEC
 ;;^UTILITY(U,$J,358.3,5379,1,4,0)
 ;;=4^I96.
 ;;^UTILITY(U,$J,358.3,5379,2)
 ;;=^5008081
 ;;^UTILITY(U,$J,358.3,5380,0)
 ;;=K85.1^^40^366^15
 ;;^UTILITY(U,$J,358.3,5380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5380,1,3,0)
 ;;=3^Biliary Acute Pancreatitis
 ;;^UTILITY(U,$J,358.3,5380,1,4,0)
 ;;=4^K85.1
 ;;^UTILITY(U,$J,358.3,5380,2)
 ;;=^5008883
 ;;^UTILITY(U,$J,358.3,5381,0)
 ;;=K85.2^^40^366^6
 ;;^UTILITY(U,$J,358.3,5381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5381,1,3,0)
 ;;=3^Alcohol Induced Acute Pancreatitis
